Table 1.
Study Type | Study Subject | UV Dose | Inflammatory Cytokine | Aging Phenotype | Reference |
---|---|---|---|---|---|
In-vivo | DBA/2 mice | 180 mJ/cm2 | TNF-α | Increase epidermal thickness, neutrophil infiltration | [47] |
In-vivo | HR-1 hairless mice | 100 mJ/cm2 | TNF-α, COX-2, iNOS, IL-6, IL-1β | Skin wrinkle formation, increase epidermal thickness, collagen degradation, mast cell infiltration | [51] |
In-vivo | HR-1 hairless mice | 100 mJ/cm2 | TNF-α, IL-6, IL-1β | Skin wrinkle formation, increase epidermal thickness, collagen degradation, trans epidermal water loss (TEWL) of dorsal skin |
[52] |
In-vivo | Chinese Kun Ming mice | 100–400 mJ/cm2 | IL-1β, IL-6, TNF-α, COX-2, PGE2, MMP-1, MMP-3 | Coarse wrinkles, erythema, edema, thickening, leathery appearance, epidermal hyperplasia, reduced collagen fibers | [53] |
In-vivo | SKH-1 hairless mice | 100 mJ/cm2 | TNF-α, MMP-13, IL-1 β, IL-6 | Increase epidermal thickness, collagen degradation | [54] |
In-vivo | hairless mice (HRS/J) | 0.384 mW/ cm2 | TNF-α, IL-6, IL-1β | Increase epidermal thickness, collagen degradation, mast cell infiltration | [55] |
In-vivo | hairless mice | 312 nm and 790 µW/cm2 intensity | IL-6, IL-12, TNF-α | Skin wrinkle formation, increase epidermal thickness, collagen degradation, collagen and elastic fibers’ (elastin) degradation |
[39] |
In-vivo | ICR mice | UVA: 20.81 J/cm2, UVB: 0.47 J/cm2 | MMP-1, MMP-3, TNF-α | Thicker scarf-skin, and a disruption of the skin tissue in dermis | [56] |
In-vitro | HaCaT and HDFs | 200 mJ/cm2 | TNF-α, IL-1β | Increase senescence-associated β -galactosidase activity, increase ROS production | [57] |
In-vivo | Wister rat | 280–400 nm | IL-6, IL-1β, TNF-α | Increase epidermal thickness, disrupted stratum corneum, abnormal hair follicles and loss of histological architecture, uneven sebaceous glands dermis, reduced skin collagen and elastic fibers |
[58] |
In-vivo and In-vitro | HaCaT | 20 mJ/cm2 | COX-2, MMP-1, FGF, TNF-α, IL-6, and decreased TGF-β1 | Increase ROS production, DNA oxidative damage, reduce procollagen type I | [59] |
Kunming mice | 150–300 mJ/cm2 | Not investigated | Increase epidermal and dermis thickness, infiltrationof inflammatory cells, decrease collagen fibers |
||
In-vivo | hairless BALB/c | 55 mJ/cm2 | TNF-α, IL-1β, IL-6 | Increase epidermal and dermis thickness, skin erythema, dry, thickening, sagging, coarse wrinkles, and reduced skin collagen type I |
[60] |
In-vitro and ex-vivo | NHDFs | 144 mJ/cm2 | TNF-α, IL-6, iNOS, COX-2 | Increase ROS production | [61] |
Reconstructed human skin (Keraskin™ FT) |
100 mJ/cm2 | Not investigated | Wrinkle formation, disruption and decomposition of collagen fibers in skin tissues exposed to UVB |
||
In-vivo and In-vitro | HaCaT | 75 mJ/cm2 | TNF-α, IL-6, MMP-1 | Not investigated | [62] |
hairless mice | 100 mJ/cm2 | MMP-9, MMP-13 | Increase epidermal and dermis thickness | ||
In-vivo | Human | 25–50 J/ cm2 | IL-6 | Not investigated | [63] |
In-vivo | hairless mice | 45–210 mJ/cm2 | MMP-2, 9, 12 and 13, TNF-α, IL-1β | Increase epidermal thickness, decrease Type I collagen, deep wrinkle formation | [64] |
In-vivo | Human | 70 and 90 mJ/cm2 | TNF-α, MMP-1 | Decrease Type I procollagen | [65] |
In-vivo | Kunming mice | 1 to 4 MED, 1 MED = 70 mJ/cm2 | IL-1β, IL-6, IL-10, TNF- α, MMP-1, MMP-3 | Reduce skin elasticity, coarse wrinkle formation, erythema, increase epidermal thickness, decrease collagen content | [66] |
In-vivo and In-vitro | HaCaT cell | 10 mJ/cm2 | IL-1α, IL-1β, IL-6, TNF-α, MMP-2/9 |
Increase ROS production | [67] |
BALB/c mice | 180 mJ/cm2 | Not Investigated | Increase epidermal thickness, infiltration of leucocyte | ||
In-vivo | SKH-1 hairless mice | 30 to 120 mJ/cm2 | MMP-1, 2, 9, COX2, IL-1β, IL-6 | Increase epidermal and dermal thickness, thick and deep wrinkle formation, decrease collagen content | [68] |
In-vivo and In-vitro | HaCaT cell | 50 J/m2 | COX-2 IL-1β, IL-6, TNF-α, MMP1, MMP2, MMP9 | Increase cellular senescence | [69] |
BALB/c athymic nude mice | 60 to 120 mJ/cm2 | COX-2, IL-1β | Increase epidermal thickness, wrinkle formation | ||
In-vivo | Kunming mice | 1 to 4 MED, 1 MED = 70 mJ/cm2 | IL-1β, IL-6, IL-10, TNF-α | Deep wrinkles, erythema, edema, and skin burn, increase epidermal thickness, degrade dermal collagen fibers, suppress antioxidant enzymes |
[70] |
In-vivo | Kunming mice | 75 to 300 mJ/cm2 | MMP-1, MMP-3, IL-6, TNF-α, IL-1 | Edema, erythema, thickening and coarse wrinkles, epidermal hyperplasia, disorganized collagen fibers |
[71] |
In-vitro | HaCaT cell | 15 mJ/cm2 | COX-2, TNF-α, IL-1β | Increase ROS production, suppress antioxidant enzymes | [72] |
In-vivo and In-vitro | HaCaT cell | 12.5 mJ/cm2 | TNF-α, IL-1 α, MMP-1, COX-2 | Not investigated | [73] |
SKH-1 hairless mice | 36–122 mJ/cm2 | MMP-1 | Increase epidermal and dermal thickness, decrease Type I collagen | ||
In-vivo | KM mice | 1–4 MED, 1 MED = 100 mJ/cm2 | IL-10, IL-6, TNF-α, MMP-1, MMP-3 | Severe wrinkles, increase epidermal thickness, decease antioxidant enzymes | [74] |
In-vivo and In-vitro | NHDFs | 90 mJ/cm2 | MMP-1, IL-1 α, IL-1β, IL-6, TNF-α | Increase ROS production | [75] |
BALB/c mice | 90 mJ/cm2 | IL-8 | Wrinkle formation, epidermal hyperplasia | ||
In-vivo | SKH-1 hairless mice | 100–200 mJ/cm2 | MMP-1, MMP-9, decreased TGF-β1 | Increase epidermal thickness, reduce procollagen type I | [76] |
In-vivo | SKH-1 hairless mice | 280–320 nm | Reduced klotho | Hyper-thickened epidermis | [18] |
HaCaT, Human epidermal keratinocytes; HDFs, Human dermal fibroblasts; NHDFs, Normal human dermal fibroblasts, HSF2; Human skin fibroblasts; MED, minimal erythemal dose; TNF-α, tumor necrosis factor-a; COX-2, cyclooxygenase-2; iNOS, Inducible nitric oxide synthase; IL, Interleukin; PGE2, Prostaglandin E2; MMP, Matrix metalloproteinase; FGF, Fibroblast growth factors; TGF-β1, Transforming growth factor beta 1; ROS, reactive oxygen species.